Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for CytRx Corporation (CYTR : OTC)
 
 • Company Description   
CYTRX CORP. is engaged in the development and commercialization of pharmaceutical related products and services including human therapeutics focused on high-value critical- care therapies.

Number of Employees: 3

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.14 Daily Weekly Monthly
20 Day Moving Average: 147,231 shares
Shares Outstanding: 43.48 (millions)
Market Capitalization: $6.25 (millions)
Beta: 2.18
52 Week High: $3.46
52 Week Low: $0.09
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 0.14% 12.78%
12 Week -68.76% -65.66%
Year To Date -71.54% -68.55%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
11726 SAN VICENTE BOULEVARD SUITE 650
-
LOS ANGELES,CA 90049
USA
ph: 310-826-5648
fax: 310-826-6139
info@cytrx.com http://www.cytrx.com
 
 • General Corporate Information   
Officers
Stephen Snowdy - Chief Executive Officer
Louis Ignarro - Chairman
John Y. Caloz - Chief Financial Officer
Jennifer Simpson - Director
Joel Caldwell - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 232828608
SIC: 2836
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/11/22
Share - Related Items
Shares Outstanding: 43.48
Most Recent Split Date: 11.00 (0.17:1)
Beta: 2.18
Market Capitalization: $6.25 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/11/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 4.93
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: 0.00%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/22 - -285.82
12/31/21 - -212.62
09/30/21 - -67.61
ROA
03/31/22 - -126.78
12/31/21 - -115.37
09/30/21 - -45.39
Current Ratio
03/31/22 - 1.99
12/31/21 - 2.22
09/30/21 - 5.94
Quick Ratio
03/31/22 - 1.99
12/31/21 - 2.22
09/30/21 - 5.94
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Book Value
03/31/22 - 0.03
12/31/21 - 0.02
09/30/21 - 0.26
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©